Literature DB >> 33094445

Managing Interstitial Cystitis/Bladder Pain Syndrome in Older Adults.

Alyssa Gracely1, Anne P Cameron2.   

Abstract

In this review, the current literature regarding pharmacotherapy treatment strategies available for the management of interstitial cystitis/bladder pain syndrome in older adults is addressed. The focus is on those treatments described by the American Urologic Association guidelines, organized according to clinical phenotype. Symptoms at presentation can vary with age, with older adults being more likely to experience nocturia, urinary incontinence, and Hunner's lesions than their younger counterparts. As such, treatment of interstitial cystitis/bladder pain syndrome should follow an individualized multimodal plan based on the patient's unique phenotype(s), starting with the most conservative options and escalating as needed. The side-effect profile and medication interactions should be reviewed, especially when treating older adults, requesting the aid of pharmacists or the primary care physician as needed to safely provide treatment.

Entities:  

Year:  2020        PMID: 33094445     DOI: 10.1007/s40266-020-00810-w

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  109 in total

1.  Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States.

Authors:  Sandra H Berry; Marc N Elliott; Marika Suttorp; Laura M Bogart; Michael A Stoto; Paul Eggers; Leroy Nyberg; J Quentin Clemens
Journal:  J Urol       Date:  2011-06-16       Impact factor: 7.450

2.  Symptom profile variability of interstitial cystitis/painful bladder syndrome by age.

Authors:  Soroush Rais-Bahrami; Justin I Friedlander; Amin S Herati; Mostafa A Sadek; Marina Ruzimovsky; Robert M Moldwin
Journal:  BJU Int       Date:  2011-08-24       Impact factor: 5.588

Review 3.  Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network.

Authors:  J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis
Journal:  Nat Rev Urol       Date:  2019-03       Impact factor: 14.432

4.  Prevalence of interstitial cystitis symptoms in a managed care population.

Authors:  J Quentin Clemens; Richard T Meenan; Maureen C O'Keeffe Rosetti; Sheila O Brown; Sara Y Gao; Elizabeth A Calhoun
Journal:  J Urol       Date:  2005-08       Impact factor: 7.450

Review 5.  Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.

Authors:  Philip M Hanno; Deborah Erickson; Robert Moldwin; Martha M Faraday
Journal:  J Urol       Date:  2015-01-23       Impact factor: 7.450

6.  Improving the utility of clinical phenotyping in interstitial cystitis/painful bladder syndrome: from UPOINT to INPUT.

Authors:  Alice Crane; Jessica Lloyd; Daniel A Shoskes
Journal:  Can J Urol       Date:  2018-04       Impact factor: 1.344

7.  Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome.

Authors:  Ming-Huei Lee; Kun-Min Chang; Wen-Chen Tsai
Journal:  Int Urogynecol J       Date:  2018-03-12       Impact factor: 2.894

8.  Status of international consensus on interstitial cystitis/bladder pain syndrome/painful bladder syndrome: 2008 snapshot.

Authors:  Philip Hanno; Roger Dmochowski
Journal:  Neurourol Urodyn       Date:  2009       Impact factor: 2.696

9.  Bladder pain syndrome/interstitial cystitis in a Danish population: a study using the 2008 criteria of the European Society for the Study of Interstitial Cystitis.

Authors:  Benedikte Richter; Ulrik Hesse; Alastair B Hansen; Thomas Horn; Svend O Mortensen; Jørgen Nordling
Journal:  BJU Int       Date:  2009-09-14       Impact factor: 5.588

Review 10.  EAU guidelines on chronic pelvic pain.

Authors:  Magnus Fall; Andrew P Baranowski; Sohier Elneil; Daniel Engeler; John Hughes; Embert J Messelink; Frank Oberpenning; Amanda C de C Williams
Journal:  Eur Urol       Date:  2009-08-31       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.